Collegium Pharmaceutical (NASDAQ: COLL) revenue
Collegium Pharmaceutical reported revenue of $780.6m for fiscal 2025, 23.6% more than in fiscal 2024 ($631.4m). Since fiscal 2016 its revenue has grown by 45,520.5%, an average growth of 97.5% a year.
Collegium Pharmaceutical has grown its revenue for 4 years in a row, and fiscal 2025 is the highest of its 10 fiscal years on record. The biggest drop was in fiscal 2021, −10.7%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $780.6m | +23.6% | $179.6m | 23.0% |
| 2024 | $631.4m | +11.4% | $169.9m | 26.9% |
| 2023 | $566.8m | +22.2% | $167.0m | 29.5% |
| 2022 | $463.9m | +67.6% | $33.3m | 7.2% |
| 2021 | $276.9m | −10.7% | $17.6m | 6.4% |
| 2020 | $310.0m | +4.5% | $56.2m | 18.1% |
| 2019 | $296.7m | +5.8% | −$23.7m | −8.0% |
| 2018 | $280.4m | +884.7% | −$20.7m | −7.4% |
| 2017 | $28.5m | +1,564.3% | −$75.4m | −264.9% |
| 2016 | $1.7m | — | −$94.1m | −5,498.7% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Collegium Pharmaceutical revenue compared with its sector
By revenue for its latest fiscal year, Collegium Pharmaceutical ranks 169th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Collegium Pharmaceutical, 23.6%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 167th | GoodRx | $796.9m | 0.6% |
| 168th | U S Physical Therapy | $781.0m | 16.3% |
| 169th | Collegium Pharmaceutical | $780.6m | 23.6% |
| 170th | Alphatec | $764.2m | 25.0% |
| 171st | iRhythm | $747.1m | 26.2% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Collegium Pharmaceutical
- How much revenue did Collegium Pharmaceutical make in fiscal 2025?
- Collegium Pharmaceutical reported revenue of $780.6m for fiscal 2025, compared with $631.4m in fiscal 2024.
- How much has the revenue of Collegium Pharmaceutical grown?
- Between fiscal 2016 and fiscal 2025 it went from $1.7m to $780.6m: 45,520.5% more, an average growth of 97.5% a year.
- What was the best year for revenue at Collegium Pharmaceutical?
- Of its last 10 fiscal years, fiscal 2025, with $780.6m.
- Where does Collegium Pharmaceutical rank in its sector by revenue?
- It ranks 169th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Collegium Pharmaceutical come from?
- From the annual report (Form 10-K) that Collegium Pharmaceutical files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Collegium Pharmaceutical files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Collegium Pharmaceutical: the Collegium Pharmaceutical page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.